Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 Oct 7;24(1):119–127. doi: 10.1158/1055-9965.EPI-14-0815

Table 4.

Determinants of cotinine and nicotine glucuronidation.

A. Cotinine Glucuronidation

Model: R-square N Percent Variation Explained
Cotinine Glucuronidation: Nicotine Equivalents 0.0001 2239 NA
  + Sex 0.0005 2239 0.04%
  + Age 0.0037 2239 0.32%
  + Race 0.0887 2239 8.50%
  + Principal Components 1–10 0.1114 2239 2.27% Base
Base Model - Cotinine Glucuronidation = Nicotine Equivalents + Sex + Age + Race + Principal Components 1–10 Data
Base Model + 15 SNPs from Stepwise 0.4433 2239 33.19% Compared to Base
Base Model + Weighted GS with 15 SNPs from Stepwisea 0.4246 2239 31.32% Compared to Base
B. Nicotine Glucuronidation

Model: R-square N Percent Variation Explained
Nicotine Glucuronidation: Nicotine Equivalents 0.0068 2239 NA
  + Sex 0.0069 2239 0.01%
  + Age 0.0121 2239 0.52%
  + Race 0.0447 2239 3.26%
  + Principal Components 1–10 0.0513 2239 0.66% Base
Base Model - Nicotine Glucuronidation = Nicotine Equivalents + Sex + Age + Race + Principal Components 1–10 Data
Base Model + 2 SNPs from Stepwise (rs116224959 & rs4132568) 0.1412 2239 8.99% Compared to Base
Base Model + CotGluc Weighted GS with 15 SNPs from Stepwise (from Model in 4a) 0.1365 2239 8.52% Compared to Base
a

The Weighted GS was weighted with the betas from the overall GWAS results.